Nephron Sterile Compounding Center LLC recalls Rocuronium Bromide Injection, 50 mg/5 mL (10 mg/mL), 5 x 5 mL Pre-Filled Syringe, 6 x 5 syringe carton, Rx Only, Nephron…
Lack of Assurance of Sterility
Read the official notice →- Date
- 2023-01-18
- Country
- United States
- Brand
- Nephron Sterile Compounding Center
- Product
- Rocuronium Bromide Injection, 50 mg/5 mL (10 mg/mL), 5 x 5 mL Pre-Filled Syringe, 6 x 5 syringe carton, Rx Only, Nephron 503B outsourcing…
- Classification
- Class II
- Units
- Nationwide in the USA.
- Category
- Drugs & medical
- Source
- FDA · Drug
Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer
What to do
- Check the product name, strength and lot number against the official notice.
- Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
- Ask the pharmacy or supplier about a replacement or refund.
General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.
More Nephron Sterile Compounding Center recalls
- 2025-03-19
USNephron Sterile Compounding Center LLC recalls Sodium Chloride Injection 9%, USP, 500 mL, Single-Dose IV Bottle, Rx Only, nephron, 503B outsourcing facility, West…
Lack of Assurance of Sterility: There is a potential for leakage at the IV bottle port.
- 2023-03-08
- US
- 2022-11-23
- US
Nephron Sterile Compounding Center LLC recalls PF-Neostigmine Methylsulfate Injection, USP 3 mg/3 mL (1 mg/mL) vial, Rx Only, Nephron 503B Outsourcing Facility 4500…
CGMP Deviations: Potential for cross contamination due to product carry over.
- 2022-08-24
- US
Nephron Sterile Compounding Center LLC recalls PF-Neostigmine Methylsulfate Injection, USP, 3 mg/3 mL (1 mg/mL), One 3 mL Unit-Dose Vial, packaged in 30 x 3 mL Sterile…
CGMP Deviations: Potential for cross-contamination due to product carryover during manufacturing.
- 2022-07-27
- US
- 2022-06-08
- US
Other drugs & medical recalls in the United States
- 2023-01-18
- US
- US
Direct Rx recalls Moxifloxacin Ophthalmic Solution, 0.5%, 3 mL, Rx Only, Packaged and Distributed By: Direct Rx, LLC 94 Worldwide Drive, Dawsonville, GA…
cGMP deviation: discontinue of stability support for product.
- US
Lupin Pharmaceuticals Inc. recalls Rifampin Capsules USP, 300 mg, 30-count bottle; Rx Only, Manufactured for: Lupin Pharmaceuticals Baltimore, Maryland 21202,…
Failed Impurities/Degradation Specifications: Failure observed in related substance testing during long term stability study.
- US
RemedyRepack Inc. recalls Rifampin Capsules, 300 mg, 30 count blister card, Rx only, Mfg: Lupin Pharma, Baltimore, MD 21202, original NDC 68180-0659-07, Repackaged…
Failed Impurities/Degradation specifications
- 2023-01-11
- US
DeRoyal Industries Inc recalls DeRoyal Tonsillectomy Tray, REF 89-10698.01
DeRoyal is recalling certain lots of surgical procedure pack products that contain a ConMed Foot Controlled Electrosurgical Suction Coagulator. The recall is due to ConMed receiving reports that the suction ports may…
- US
Randox Laboratories Ltd. recalls Liquid Assayed Specific Protein Control Level 2- In vitro diagnostic use, in the quality control of serum on clinical chemistry and…
Concentration of Rheumatoid Factor has decreased in Specific Protein Control Level 1-3 causing delay in reporting results due to Quality Controls running low outside range
FDA · DeviceRandox Laboratories Ltd.US Nationwide distribution in the states of CA, FL, OH,ME, MO, NC, NJ, PA, TN.Official notice →